Skip to content

Saffron in the treatment of post-partum depression

Comparison of saffron and fluoexetine in the treatment of mild to moderate post partum depression :A duble –blind clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201509201556N82
Enrollment
50
Registered
2015-09-21
Start date
2015-09-25
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post partum depression. Mental and behavioural disorders associated with the puerperium, not elsewhere classified

Interventions

Intervention 1: Capsule fluoxetine 20 to 40mg/day as icontrol group for 6 weeks. Intervention 2: Capsule saffron 15mg BID as intervention group for 6 weeks.
Treatment - Drugs
Capsule fluoxetine 20 to 40mg/day as icontrol group for 6 weeks
Capsule saffron 15mg BID as intervention group for 6 weeks

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Presence of Major Depressive Disorder; with peripartum onset based on DSM-5 criteria; age between 18 to 45 years old; score lower than 18 in Hamilton Rating Scale for depression. Exclusion criteria: -Psychotic symptoms or any other major psychiatric disorder; receiving any antidepressants during past one month or ECT during past two months; Presence of hypothyroidism or hyperthyrodism; srious suicidality or infanticide ideas; substance abuse or dependence uring the last three months

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of depression. Timepoint: Baseline and weeks 2-4-6 after beginig of treatment. Method of measurement: by Hamiltion Depression Rating Scale 17-Item.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactProf. Shahin Akhondzadeh

Tehran University of Medical Sciences

S.akhond@sina.tums.ac.ir+98 21 5541 2222

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026